Flagship Labs 103, Inc. (FL103) is an early-stage company developing advanced molecular technologies for early disease detection using minimally invasive biospecimens. They aim to enable earlier disease detection, longitudinal disease monitoring, and improved patient stratification across oncology, neurodegenerative disease, and other major disease areas. FL103 was founded by Flagship Pioneering, an innovation enterprise focused on creating companies with breakthrough technologies. FL103 is seeking a scientific and operational leader to translate early assay and biological discoveries into robust, scalable, and clinically meaningful diagnostic assays. This role involves driving the development and optimization of highly multiplexed molecular assays for plasma-based applications, focusing on improving assay sensitivity, specificity, reproducibility, and analytical performance. The ideal candidate will have expertise in translational assay development within molecular diagnostics, liquid biopsy, or advanced biomarker platforms, and experience converting complex biological signals into deployable diagnostic workflows. The role requires operating as a player-coach in a collaborative, fast-moving environment, building and mentoring a growing product development organization.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Senior
Education Level
Ph.D. or professional degree